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ABSTRACT 
 
Apoptosis is essential not only to the normal development of a multicellular 
organism but also for the maintenance of tissue homeostasis.  This proposal seeks to 
investigate, in part, the role of oligodendrocyte (OL) apoptosis in myelination.  We used 
an OL-specific conditional knockout animal to study caspase-8 function in OL 
development; analyzing histological differences in myelination at postnatal day 10 and 
alterations to OL proliferation, differentiation, and cell death in culture.  Our preliminary 
data suggests that deletion of caspase-8 did not alter OL proliferation or differentiation 
in culture, but reduced the percentage of apoptotic cells following nutrient deprivation.  
In vivo, we found an increase in myelinated axons in the spinal cord of caspase-8 
deficient mice, indicating a role for caspase-8 in the myelination process.   
This study also seeks to investigate mechanisms of cell death in OLs, astrocytes, 
and neurons following oxidative injury.  Exposure of primary OLs, astrocytes, and 
neurons to arachidonic acid (AA) resulted in oxidative stress and cell death.  
Necrostation-1, the specific inhibitor of receptor interacting protein kinase 1 (RIP-1), 
markedly prevented AA-induced oxidative death in OLs and astrocytes, but not in 
neurons.  Similarly, we found that blockade of 12-lipoxygenase (LOX) and c-Jun N-
terminal kinase (JNK) protected OLs and astrocytes but not neurons against AA toxicity.  
Consistent with the inability of necrostatin-1 to rescue neurons, we found very low 
expression of RIP-1 as well as RIP-3 in neurons.  Finally, the zinc chelator TPEN 
effectively abolished AA-induced oxidative death in all three cell types, suggesting zinc 
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release as a common mechanism.  Taken together, our findings indicate differences in 
cell death mechanisms following oxidative injury in astrocytes, OLs, and neurons. 
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NOMENCLATURE 
 
AA   Arachidonic Acid 
bFGF   Basic Fibroblast Growth Factor 
cDNA   Complimentary DNA 
cKO                Conditional Knockout 
CNS   Central Nervous System 
GFAP   Glial Fibrillary Acidic Protein 
JNK   c-Jun N-terminal Kinase  
KO                  Knockout  
LDH   Lactate Dehydrogenase 
LOX   Lipoxygenase 
OL    Oligodendrocyte 
OPC   Oligodendrocyte Precursor Cell 
PCD               Programmed Cell Death 
PDGF   Platelet Derived Growth Factor 
Pre-OL  Pre-Oligodendrocyte 
Rho 123  Rhodamine 123 
RIP-1   Receptor Interacting Protein Kinase 1 
RIP-3   Receptor Interacting Protein Kinase 3 
ROS   Reactive Oxygen Species  
SVZ   Subventricular Zone 
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TUNEL           Terminal Deoxynucleotidyl Transferase dUTP Nick End Labeling 
WT                  Wildtype 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 vii 
TABLE OF CONTENTS 
Page 
ABSTRACT .................................................................................................................   ii 
ACKNOWLEDGEMENTS .........................................................................................  iv 
NOMENCLATURE .....................................................................................................   v 
TABLE OF CONTENTS ............................................................................................. vii 
LIST OF FIGURES ......................................................................................................  ix 
LIST OF TABLES .......................................................................................................   x 
CHAPTER I INTRODUCTION TO APOPTOSIS AND OXIDATIVE INJURY ......   1 
Apoptosis ..........................................................................................................   1 
Oxidative injury ................................................................................................   5  
CHAPTER II METHODS AND MATERIALS ..........................................................   9 
Materials and animals .......................................................................................   9 
Generation of oligodendrocyte-specific caspase-8 knockout mice ..................   9 
Genotyping and PCR ........................................................................................ 10 
Primary glial cell cultures ................................................................................ 11 
Isolation of oligodendrocytes ........................................................................... 11 
Isolation of astrocytes ....................................................................................... 12 
Primary neuron cell cultures ............................................................................ 12 
Immunohistochemistry ..................................................................................... 13 
Transmission electron microscopy ................................................................... 13 
Reverse transcription PCR ............................................................................... 14 
            Western blots .................................................................................................... 16 
Arachidonic acid treatment .............................................................................. 16 
Viability assays ................................................................................................ 17 
Intracellular reactive oxygen species detection ................................................ 17 
Live cell staining .............................................................................................. 17 
Statistical analysis ............................................................................................ 18 
CHAPTER III RESULTS ............................................................................................ 19 
Apoptosis ........................................................................................................... 19 
 
 viii 
Page 
Oxidative injury ................................................................................................ 25 
CHAPTER IV CONCLUSION .................................................................................... 39 
Apoptosis .......................................................................................................... 39 
Oxidative injury ................................................................................................ 42 
 
REFERENCES ............................................................................................................. 46 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 ix 
LIST OF FIGURES 
 
FIGURE                                                                                                                        Page 
 
      1        Oligodendrocyte lineage progression and marker expression ......................    3 
      2        Caspase-8 deletion strategy .......................................................................... 20 
      3        Effects of caspase-8 deletion on oligodendrocyte physiology  
                in culture ....................................................................................................... 22 
      4        Caspase-8 deletion in oligodendrocytes results in more myelinated  
                axons in P10 spinal cord ............................................................................... 24 
      5        Arachidonic acid induces oxidative stress in oligodendrocytes ................... 26 
      6        Arachidonic acid induces oxidative stress in neurons through  
                different mechanisms ................................................................................... 28 
      7        Arachidonic acid induces oxidative stress in astrocytes .............................. 30 
      8        Alternative mechanisms in astrocytes under oxidative stress ...................... 31 
      9        Live cell imaging of astrocyte lysosome formation and  
                mitochondrial health ..................................................................................... 33 
      10      Zinc release following arachidonic acid treatment ...................................... 34 
      11      Receptor interacting protein kinase 1 involvement in  
                arachidonic acid-induced toxicity ................................................................ 36 
      12      Receptor interacting protein kinase 1 expression in  
                neurons and glia ........................................................................................... 37 
      13      Proposed schematic of caspase-8 involvement in  
                oligodendrocyte development ...................................................................... 40 
      14      Proposed schematic of arachidonic acid-induced toxicity ........................... 45 
 
 
 
 x 
LIST OF TABLES 
TABLE                                                                                                                          Page 
1 Comparison of apoptosis, necroptosis, and autophagy ..............................   2 
2 Genotyping primer sequences (conditional knockout mice) ...................... 11 
3 RTPCR primer sequences (rat) .................................................................. 15 
1 
 
CHAPTER I 
INTRODUCTION TO APOPTOSIS AND OXIDATIVE INJURY 
 
Apoptosis 
Apoptosis is a form of programmed cell death (PCD) that was first described in 
mammals 40 years ago (Kerr et al., 1972).  Changes in morphological features lead 
researchers to believe the process was programmed, which was subsequently 
demonstrated in detail in Caenorhabiditis elegans (Yuan et al., 1993).  It is now well-
established that apoptosis is essential to the development and homeostasis of all 
multicellular organisms (Jacobson et al., 1997).  Apoptosis is a highly regulated process 
that selected cells undergo (Table 1).  Dysregulation of apoptosis could be disastrous for 
an organism, as is the case in many pathological conditions.  For instance, 
overexpression of anti-apoptotic proteins is often seen in cancers, while wide-spreading 
apoptotic cascades often increase the damage seen in degenerative conditions such as 
stroke. 
Many mammalian apoptogenic and anti-apoptotic genes have been identified 
(Metzstein et al., 1998).  The central mediators of apoptosis are the caspases.  They are a 
family of cysteine proteases that employ a cysteine residue as the catalytic nucleophile.  
They exist in the cytoplasm as zymogens.  Caspase-8 is known to be an upstream 
member in apoptosis signaling; it dimerizes and undergoes proteolytic cleavage 
following the activation of the death-receptors, such as TNF and FAS receptors (Zhao et 
al., 2010).   
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Table 1 – Comparison of apoptosis, necroptosis, and autophagy 
Factors 
 
Apoptosis Necroptosis Autophagy 
Morphology 
 
 
 
 
Chromatin 
condensation, nuclear 
fragmentation, apoptotic 
bodies 
Organelle swelling, 
plasma membrane 
rupture 
Autophagic 
vacuoles 
Triggers Death receptors, trophic 
factor withdrawal, DNA 
damage, viral infection 
Ischemia, 
neurodegenerative 
disease, viral 
infection 
 
Amino acid 
starvation, 
protein 
aggregation 
Mediators Caspases, BH1-3, BCL2 
family proteins 
RIP-1/3, JNK, 
LOX, CYLD 
Phosphoinositide
-3 kinase, mTOR 
 
 
Apoptosis, is essential to the development of the central nervous system (CNS) 
(Hidalgo and ffrench-Constant, 2003), but the role of caspase-8 in CNS development 
remains unknown.  To better understand the function of caspase-8 during development, a 
complete ablation genetic model was established (Varfolomeev et al., 1998), which was 
found to be embryonically lethal due to brain and heart malformations (Varfolomeev et 
al., 1998).  Later, it was discovered that brain malformation is likely a secondary issue 
due to a failure to properly develop yolk sac vasculature in the caspase-8 knockout mice 
(Sakamaki et al., 2002).  
OLs are glial cells in the CNS that ensheath axons with myelin, allowing rapid 
propagation of action potential (Bunge, 1968, Baumann and Pham-Dinh, 2001, Nicolay 
et al., 2007).  Myelinating OLs are highly differentiated cells.  OLs mature during 
development from oligodendrocyte precursor cells (OPCs), gradually continuing to 
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mature through different stages, which can be immunohistochemically identified by their 
distinct surface expression of different proteins and/or certain lipids (Pringle et al., 1992) 
(Figure 1).  OLs primarily develop in early postnatal life from OPCs that migrated from 
the subventricular zone (SVZ) (Vallstedt et al., 2005). Once positioned, they begin to 
proliferate and then differentiate and eventually mature into myelin-producing mature 
OLs (Hardy and Reynolds, 1991, Levison and Goldman, 1993).   
 
               
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 – Oligodendrocyte lineage progression and marker expression.  The progression of oligodendrocytes from 
progenitors to myelinating cells.  PDGFR = platelet-derived growth factor receptor; CNP= 2´, 3´-Cyclic nucleotide 3´-
phosphodiesterase; MAG = myelin-associated glycoprotein; MBP = myelin basic protein; MOG = myelin 
oligodendrocyte glycoprotein; PLP = proteolipid protein.  Image adapted from Back, S. A. and S. A. Rivkees (2004).  
“Emerging concepts in periventricular white matter injury.” Seminars in Perinatology 28(6): 405-414. 
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Myelination is a multistep and complex process of which the detailed molecular 
mechanisms remain incompletely understood.  It has been shown previously that OLs 
receive survival signals from the axons they myelinate (Barres and Raff, 1999).  OL 
lineage cells are produced abundantly during CNS development, and it has been 
postulated that a competition for survival signals produced by axons leads to appropriate 
elimination of excess OL lineage cells.  Excess OL lineage cells appear to undergo 
apoptosis (Barres et al., 1992).  This process ensures that OLs are matched perfectly to 
the axonal surface area for subsequent myelination and promotion of action potential 
propagation (Barres and Raff, 1999).  We hypothesized that caspase-8 could be involved 
in this process of eliminating excess OLs, a possibility that has not been examined 
previously and was explored in this study. 
Although the death-receptors and caspases have been implicated in many 
neurological disorders, to date, no study has directly investigated the in-vivo function of 
caspase-8 in the CNS during normal development.  This is, in part, due to a lack of 
available conditional caspase-8 knockout mice where caspase-8 is specifically deleted in 
CNS cells, as global deletion of caspase-8 is embryonically lethal (Busso et al., 2010).  
To determine the role of caspase-8 in OLs during development, we utilized lox-P Cre 
technology to specifically ablate caspase-8 in OL lineage cells in mice.   
Our study aims to investigate the function of caspase-8 in this context.  Since OLs 
have the potential to myelinate up to 50 axons per cell, alterations in the number of OLs 
in the developing brain could have a powerful impact on normal brain function.  Our 
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central hypothesis is that caspase-8 is involved in controlled elimination of superfluous 
or non-functioning OL lineage cells during development. 
Oxidative injury 
 Oxidative stress is defined primarily as the loss of a cell’s ability to manage the 
production and elimination of oxidative radicals (Finkel and Holbrook, 2000).  Oxidative 
radicals can be produced by the redox reactions that cells perform on a regular basis for 
the synthesis and degradation of essential molecules and during energy production in the 
electron transport chain.  It is within the ability of a healthy cell to quickly eliminate 
radicals produced by normal biological processes with minimal damage.  The 
accumulation of oxidative radicals, such as peroxides and superoxide radicals, can lead 
to damage.  Oxidative stress is involved in many neurological diseases, including stroke 
(van Leyen et al., 2006), periventricular leukomalacia (Inder et al., 2002), Parkinson’s 
disease (Thompson et al., 2000), and Alzheimer’s disease (Behl et al., 1992, Behl et al., 
1994). 
 Oxidative stress is a complex process that can be exacerbated by both intracellular 
and extracellular stress and/or processes, such as heavy metal release. Zinc has been 
implicated in oxidative stress (Zhang et al., 2007).  It is an abundant trace element in 
mammals (Weiss et al., 2000, Moos et al., 2007) and the release of intracellular stores, 
which can be caused by oxidative stress, has been shown to lead to rapid cell death (Choi 
and Koh, 1998, Frederickson et al., 2005). 
AA levels have been shown to increase after brain ischemia (Katsuki and Okuda, 
1995).  AA is a 20 carbon, omega-6 polyunsaturated fatty acid that can be found in 
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organs throughout the body and quite abundantly in the brain.  It is often a component of 
the phospholipid bilayer and can be released when phospholipase A2 hydrolyzes the acyl 
bond of phospholipids, creating free AA.  It is involved in cellular signaling as a lipid 
second messenger.  It is also a precursor for the formation of many essential molecules 
including thromboxane, prostaglandin, prostacyclin, and leukotriene.  AA is a known 
substrate for cycloxygenases and lipoxygenases whose natural metabolism is a source of 
peroxides and free radicals.  Changes in AA metabolism have been implicated in 
cerebral ischemic injury, inflammation, and several neurological disorders (Simonian 
and Coyle, 1996, Phillis et al., 2006).   
 Much of the neurobiological research in the past has focused on the neuron, the 
functional unit of the brain.  In recent years, however, it has become apparent that glial 
cells are much more than the brain “glue” that their name implies.  Astrocytes, in 
particular, have been found to have numerous functions.  Their processes wrap around 
blood vessels, forming one layer of the blood-brain barrier (Nedergaard et al., 2003).  
This puts them in a unique position to regulate nutrient trafficking and even carbon 
dioxide blood levels and blood pH (Gourine et al., 2010).  Their processes also contact 
neuronal synapses and are involved in reuptake of neurotransmitters, including the 
prevention of excitotoxicity by converting glutamate to glutamine (Liang et al., 2006).  
They also possess the ability to uptake large amounts of heavy metals such as copper 
that would be otherwise toxic to neurons (Tiffany-Castiglioni et al., 2011).  Due to their 
many critical functions in maintaining a microenvironment in which neurons can thrive, 
studying potentially protective mechanisms in pathological conditions is important.  
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Unfortunately this is often overlooked.  In this study we sought to examine the 
mechanisms occurring in astrocytes following AA-induced oxidative injury, as very little 
was previously known and astrocytes have the potential to sustain neurons in a toxic 
environment. 
 In cell culture, we have previously shown that AA-induced cell death of pre-
oligodendrocytes (pre-OLs) is characterized by production of reactive oxygen species 
(ROS), mediated by 12-LOX activation in the absence of caspase activation (Kim et al., 
2010).  According to classical morphological indicators such as cellular swelling and 
membrane rupture, AA clearly induces oxidative stress, leading ultimately to necrosis.  
We and others have shown that AA-induced cell death is necroptotic, a programmed 
form of necrosis, as it can be blocked using the RIP-1 inhibitor necrostatin-1 (Degterev 
et al., 2008, Kim et al., 2010). 
Necroptosis is a unique form of programmed cell death.  Although it is characterized 
by morphological hallmarks of typical necrotic cell death such as cellular swelling and 
membrane rupture, it operates in a programmed, caspase-independent manner (Table 1).  
Necroptosis is dependent on assembly and activation of RIP-1 and RIP-3 kinases.  The 
RIP kinase family has emerged as critical regulator of cellular fate.  RIP-1, in particular, 
has been shown to be a bifurcation point in cell death signaling, possessing the ability to 
promote survival or cell death (Vandenabeele et al., 2010).  Necrostatin-1 was 
discovered through chemical library screening and found to be a specific allosteric 
inhibitor of RIP-1 kinase, which has been shown to be protective in animal models of 
CNS ischemia (Degterev et al., 2005, Chavez-Valdez et al., 2012) as well as brain 
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trauma (You et al., 2008), myocardial infarction (Oerlemans et al., 2012), renal ischemia 
(Linkermann et al., 2012), and systemic inflammatory response syndrome (Duprez et al., 
2011).  However, it is not clear whether the in-vivo protective effects of necrostatin-1 are 
due to its action on neurons or glia.  We therefore investigated the protective potential of 
necrostatin-1 using the AA-induced oxidative damage model in primary OLs, astrocytes, 
and neurons.  Our central hypothesis was that necrostatin-1 acts primarily on glial cells 
to prevent necroptosis following oxidative injury. 
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CHAPTER II 
 METHODS AND MATERIALS 
 
Materials and animals 
 Dulbecco’s Modified Eagle Medium (DMEM), Hank’s Balanced Salt Solution 
(HBSS), Earl’s Balanced Salt Solution (EBSS), and fetal bovine serum were purchased 
from Hyclone (Logan, UT).  Human platelet-derived growth factor (PDGF) and basic 
fibroblast growth factor (bFGF) were from PeproTech (Rocky Hill, NJ).  The compound 
2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadynyl)-1,4-benzoquinone (AA861) was 
purchased from BioMol Research Laboratory (Plymouth, PA).  SP600125 was 
purchased from EMD Chemicals (Gibbstown, NJ).  RIP-1 and RIP-3 antibodies were 
from R&D Systems (Minneapolis, MN) and IMGENEX (San Diego, CA), respectively.  
Unless specified otherwise, all other reagents were from Sigma (St. Louis, MO).  All 
animal care protocols were in accordance with NIH guidelines for care and use of 
laboratory animals and were approved by Texas A&M University Laboratory Animal 
care and use committee. 
Generation of oligodendrocyte-specific caspase-8 knockout mice 
 Conditional knockout mice for caspase-8 were made by utilizing the lox-P Cre 
system.  Mice expressing Cre recombinase behind the OL lineage-specific promotor 
Olig 1 (Olig1-Cre) were crossed to mice (Caspase-8fl/fl) expressing lox-P sites within the 
caspase-8 gene.  This resulted in genetic ablation of caspase-8 in OL lineage cells. 
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Genotyping and PCR 
 Tail clips of 3 wk old mice were taken and the tissue was digested using a buffer 
containing 50mM Tris, 20mM NaCl, 1mM EDTA, 1% SDS, and 0.5mg/ml protease k.  
Samples were heated to 55 °C for 30 min.  500 µl of water was added to each sample 
and placed in a boiling water bath for 5 min.  Samples were then centrifuged for 10 min. 
at 13.4 rcf and placed on ice immediately.  DNA was quantified using a Nanodrop 1000 
spectrophotometer (Thermo Scientific).  PCR was then performed to test for the 
presence or absence of Olig1-Cre and Caspase-8fl/fl using specific primers (Table 2).  To 
check for Olig1-Cre we had an initial denaturing step for 3 min at 95°C, then 20 ng of 
DNA was amplified by 39 cycles of PCR (94°C for 45 sec, 58°C for 1 min, 72°C for 1 
min) followed by a final elongation step at 72°C for 3 min.  To check for Caspase-8fl/fl  
we had an initial denaturing step for 4 min at 94°C, then 20 ng of DNA was amplified by 
30 cycles of PCR (94°C for 30 sec, 62°C for 30 sec, 72°C for 30 sec) followed by a final 
elongation step at 72°C for 5 min. Samples were electrophoresed in 1% agarose gels and 
visualized under UV light using a Chemidox XRS gel documentation system (Bio-rad, 
Hercules, CA). 
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Table 2 – Genotyping primer sequences (conditional knockout mice) 
Gene Name Forward Sequence (5´ - 3´) Reverse Sequence (5´ - 3´) 
 
Olig1-Cre 
Wildtype 
 
 
GTGTTCCAAGGAGCGA 
TGTAGTTGCTTGGG 
 
CTCCTAGATCCGCATG 
GTTTGGCTGGAGAG 
Olig1-Cre 
Mutant 
 
GGACATGTTCAGGGAT 
CGCCAGGCG 
GCATAACCAGTGAAAC 
AGCATTGCTG 
Caspase-8fl/fl ATAATTCCCCCAAATC 
CTCGCATC 
TCCTGTACCATATCTGC 
CTGAACGCT 
 
 
Primary glial cell cultures 
Primary glial cultures were prepared from the forebrains of 1- to 2-day old Sprague-
Dawley rat pups using a differential detachment method as previously described 
(McCarthy and de Vellis, 1980).  Once the meninges were removed from the forebrains, 
the tissue was briefly digested using HBSS containing 0.1% trypsin and 10 μg/ml 
DNAse.  The cells were then triturated in DMEM containing 10% heat-inactivated fetal 
bovine serum and 1% penicillin-streptomycin.  Dissociated cells were plated onto 75 
cm2 poly d-lysine coated flasks and the medium was changed every other day for 7 days. 
Isolation of oligodendrocytes 
After shaking of the cells for 1 hour to remove microglia, the cultures were shaken 
overnight at 200 rpm to isolate pre-OLs.  This cell suspension was then plated onto 
uncoated petri dishes to further remove contaminating microglia/astrocytes.  The 
resulting pre-OLs were plated onto poly-ornithine coated plates and maintained in a 
serum-free defined medium (BDM, 0.1% bovine serum albumin, 50 μg/ml human apo-
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transferrin, 50 μg/ml insulin, 30nM sodium selenite, 10nM d-biotin, and 10 nM 
hydrocortisone in DMEM) supplemented with 10 ng/ml PDGF and 10 ng/ml bFGF for 
7-9 days at 37°C in a humid atmosphere of 5% CO2 and air.  Culture medium was half 
changed every other day, and the cells were used experimentally between 7-9 days in-
vitro (DIV). 
Isolation of astrocytes 
After the isolation of OLs, cell cultures were washed once with phosphate buffered 
saline (PBS).  Briefly, the cultures were treated with DMEM medium containing 0.1% 
trypsin at 37°C.  Cells were suspended in DMEM medium containing 10% fetal bovine 
serum and centrifuged at 9.3 rcf for 7 minutes.  Medium containing trypsin was aspirated 
and cells were suspended in previously mentioned media.  Cells were plated on 75 cm2 
poly d-lysine coated flasks and allowed to grow to confluency.  The cells were then 
treated with 1 µM L-leucine methylester for 1 hr at 37°C to eliminate contaminating 
microglia.  Cells were washed once with PBS and trypsinized as previously mentioned.  
Astrocytes were then plated on poly d-lysine coated plates and maintained in the 
described medium for 1-3 days before experimental use. 
Primary neuron cultures 
Cultures were taken from the forebrains of embryonic (E) day 16.5 Sprague-Dawley 
rat pups.  Briefly, forebrains free of meninges were dissected in cold dissection buffer 
(Ca2+/Mg2+-free HBSS containing 10mM HEPES), and then dissociated with papain (10 
units/ml) in dissection buffer for 5 min at 37°C.  Cells were then treated with trypsin 
inhibitor (10 mg/ml) in dissection medium for 2-3 min.  After 2 additional washes with 
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trypsin inhibitor solution, the cells were suspended in plating medium (Neurobasal, 2% 
B27, 1 mM glutamine, 25 µM glutamic acid, 100 units/ml of penicillin, and 100 µg/ml 
streptomycin).  The cells were then passed through a 70 µm cell sieve and live cells were 
counted using a hemocytometer and trypan blue exclusion assay.  Mature cortical neuron 
cultures were cultured for 14-20 days and purified by adding 10 µM fluorodeoxyuridine 
(FdU) and 10µM uridine diluted in neurobasal medium.  FdU treatment began on DIV 1, 
and cells were cycled through 2 days of treatment and 2 days without treatment for a 
total of 3 FdU cycles.  Immature neurons were cultured for 3-7 days and purified by 
adding 5 µM arabinofuranosyl cytidine (ara-c) diluted in neurobasal media for 48-72 hrs.   
Immunohistochemistry 
Cell cultures were fixed with 4% paraformaldehyde immediately following viability 
analysis.  Cells were then washed 3 times in tris-buffered saline (TBS) for 5 min, 
following by a 1 hr blocking and permeabilizing step using 5% goat serum and 0.1% 
Triton-X diluted in TBS.  Primary antibodies were incubated overnight, diluted in TBS 
as indicated below.  All secondary antibodies were purchased from Invitrogen and 
diluted to a concentration of 1:1000 in blocking solution, then incubated 1 hr at room 
temperature. 
Transmission electron microscopy 
Mice were anesthetized and perfused using PBS and then fixed with 20 ml PBS 
containing 2% paraformaldehyde and 2.5% glutaraldehyde (Electron Microscopy 
Sciences, Halflield PA) then post-fixed overnight at 4ºC.  The brains, spinal cords, and 
optic nerves were collected.  The brains were then segmented using a mouse-specific 
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alto 0.5 mm stainless steel matrix (Roboz Surgical Instrument Company, Inc. 
Gaithersburg, MD) and trimmed to 2-3 mm thick segments.  Spinal cords were cut into 
3-5 mm segments coronally.  The tissues were then washed in 0.1M sodium cacodylate 
buffer and stained using 1% osmium tetroxide and 0.5% potassium ferrocyanide in 0.5% 
sucrose for 1.5 h.  Next, the tissues were serially dehydrated in ascending alcohol series 
and embedded in epoxy resin.  Ultrathin sections of the tissue were examined with an 
FEI Morgagni 268 transmission electron microscope at an accelerating voltage of 80 kV.  
Digital images were acquired with a MegaViewIII camera operated with iTEM software 
(Olympus Soft Imaging Systems, Germany).  Image contrast was uniformly adjusted 
with Adobe Photoshop.  The number of myelinated axons was determined from 4400x 
fields from each region and was expressed as axons per mm2. 
Reverse transcription PCR 
RNA was isolated 5 hrs after AA treatment as described using the RNEasy Kit 
(Qiagen, Valencia, CA).  Samples were reverse transcribed into cDNA using a reverse 
transcription kit (Promega, Madison, WI) and random primers in the presence or absence 
of reverse transcriptase for 10 min at 25°C, followed by 15 min at 45°C, 5 min at 95°C, 
and 5 min at 4°C.  PCR was then performed to test for the presence or absence of RIP-1 
and RIP-3 using specific primers (Table 3).  Primers for GFAP and Iba-1 were used to 
examine glial contamination in neuron cultures (Table 3).  The housekeeping gene actin 
was used as a control (Table 3).   To check for RIP-1 we had an initial denaturing step 
for 10 min at 95°C, then 100 ng of cDNA was amplified by 30 cycles of PCR (95°C for 
15 sec, 56°C for 15 sec, 72°C for 30 sec) followed by a final elongation step at 72°C for 
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5 min.  To check for RIP-3 the initial denaturing step was for 2 min at 94°C, then 100 ng 
of cDNA was amplified by 35 cycles of PCR (94°C for 30 sec, 60°C for 30 sec, 72°C for 
1 min) followed by a final elongation step at 72°C for 10 min.  To check for GFAP we 
had an initial denaturing step for 5 min at 95°C, then 100 ng of cDNA was amplified by 
30 cycles of PCR (95°C for 5 sec, 62°C for 30 sec, 72°C for 1 min) followed by a final 
elongation step at 72°C for 7 min.  To check for Iba-1 and Actin we used an initial 
denaturing step for 5 min at 95°C, then 100 ng of cDNA was amplified by 30 cycles of 
PCR (95°C for 45 sec, 57°C for 45 sec, 72°C for 45 sec) followed by a final elongation 
step at 72°C for 5 min.  Samples were electrophoresed in 1% agarose gels and visualized 
under UV light using a Chemidox XRS gel documentation system (Bio-Rad, Hercules, 
CA).  
 
 
Table 3 – RTPCR primer sequences (rat) 
a – primer sequence is for mouse actin 
 
Gene name Forward sequence (5´ - 3´) Reverse sequence (5´ - 3´) 
 
RIP-1 
 
 
GCACCAGCTGTCAGGGC
CAG 
 
GCCCAGCTTTCGGGCAC
AGT 
RIP-3 
 
GCACCAGCTGTCAGGGC
CAG 
GCCCAGCTTTCGGGCAC
AGT 
GFAP 
 
AGGAAGGGTACTGCCTC
CCCC 
CCACACACAGCCTCCCTC
AGC 
Iba-1 
 
CTTTTGGACTGCTGAAAG
CC 
GTTTCTCCAGCATTCGCT
TC 
Actin a GCATGCAGAAGGAGATC
ACA 
ACATCTGCTGGAAGGTG
GAC 
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Western blots 
Cell lysates were subjected to SDS-polyacrylamide gel electrophoresis followed by 
electrotransferring onto PVDF membranes.  Nonspecific binding was blocked by 
incubating the membrane in TBS-T (50nM Tris-HCl, pH 7.4, 150mM NaCl, 0.1% 
Tween-20) containing 5% skim milk for 1 hr at room temperature.  Anti RIP-1 (1:1000 
dilution, Mse IgG, R&D Systems, MAB 3585), RIP-3 (1:1000 dilution, Rabbit IgG, 
Imgenex, IMG-5523-1), and β-actin (1:10,000 dilution, Sigma, A2066) antibodies were 
diluted in TBS-T containing 5% skim milk and incubated overnight at 4°C.  The 
membrane was then washed 3-5 times using TBS-T and incubated with horseradish 
peroxidase conjugated secondary antibody (1:1000) for 1 hr with agitation.  After 4-5 
washes with TBS-T, protein bands were visualized by chemilluminescence using the 
SuperSignal detection kit (Thermo Scientific, Rockford, IL).  
Arachidonic acid treatment 
To induce oxidative stress, freshly prepared AA (stock concentration 100 mM in 
anhydrous dimethyl sulfoxide [DMSO]) was added to cells in BDM medium.  The co-
treatment drugs necrostatin-1, baicalein, vitamin K2, and SP600125 were also made in 
anhydrous DMSO and diluted from 20mM, 100mM, 10mM, and 50mM stock solutions, 
respectively.  TPEN and AA861 were made in ethanol and diluted from 100mM and 
10mM stock solutions, respectively.  All drugs were added at the same time as AA.  The 
final concentration of DMSO in the culture medium was ≤ 0.1% and had no effect on 
cell viability, proliferation, or morphology.  DMSO was used as a vehicle control in all 
experiments. 
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Viability assays 
 Cell viability was determined 16-20 hrs after treatment using Alamar Blue 
(Southern Biotechnology, Birmingham, AL), a tetrazolium dye that is reduced by living 
cells to a colored product.  All results of cell death assays were confirmed by visual 
inspection of cells under a phase contrast light microscope.  Survival assays were 
performed in triplicate, and the results were expressed as mean ± SEM.  In some cases, 
cell toxicity was assessed by lactate dehydrogenase (LDH) release assay (Roche 
Diagnostics, Indianapolis, IN).  Briefly, culture medium was collected at the end of 
experiments and analyzed for LDH release according to the manufacturer’s protocol.   
Intracellular reactive oxygen species detection 
 Intracellular free radical accumulation was visualized using dihydrorhodamine 123 
(Rho 123; Invitrogen, Carlsbad, CA) as previously described (Kim et al., 2010). Rho 123 
was made in DMSO and diluted from a 10mM stock.  Cells were treated for 4-6 hrs with 
AA, and then 10μM Rho 123 diluted in culture medium was added to the cells for 20 
min. at 37°C.  The extracellular dye was then removed by washing the cells with warm 
EBSS twice. Live cell imaging using Rho 123 was visualized under a fluorescent 
microscope (Olympus IX71) equipped with an Olympus DP70 digital camera.  
Microscope settings such as brightness, contrast, and exposure time were held constant 
to compare intensities of oxidized Rho123 across conditions. 
Live cell staining 
 Astrocytes were treated with AA for 3 hrs and then either 1 μM FluoroZin-3 
(Invitrogen), 20nM Mitotracker Red (Invitrogen), or 1 μg/ml JC-1 (Invitrogen) was 
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added and incubated for 20 min. at 37ºC.  In addition, we incubated 50 nM DND-99 
(Invitrogen) for 5 min at 37ºC.  The cells were then washed twice with warm EBSS and 
viewed live under a fluorescent microscope (Olympus IX71) equipped with an Olympus 
DP70 digital camera.  Microscope settings such as brightness, contrast, and exposure 
time were held constant to compare intensities across conditions. 
Statistical analysis 
All cell culture experimental conditions were performed in triplicate.  GraphPad 
Prism software was used for data analysis.  One-way ANOVA with a Bonferroni 
Posthoc test was used to determine statistical significance unless otherwise indicated.  
P<0.05 was considered statistically significant.  Results are presented as mean ± SEM.  
P<0.05, *; P<0.01, **; P<0.001, ***. 
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CHAPTER III 
RESULTS 
 
Apoptosis 
Generation of oligodendrocyte-specific caspase-8 knockout animals 
 OL lineage–specific caspase-8 conditional knockout (cKO) mice were generated 
by mating mice that have exon 2 of the caspase-8 gene floxed to mice expressing cre 
recombinase behind the OL-specific promotor Olig1.  Expression of cre recombinase 
resulted in excision of the floxed exon 2, rendering the gene nonfunctional (Figure 2A).  
To verify the deletion of caspase-8 specifically in OLs, we designed primers that bind to 
the introns upstream and downstream of the lox-P sites (Figure 2A).  When exon 2 is 
deleted, the primers amplify a 200 base pair band (Figure 2B).  The absence of a 700 
base pair wild type (WT) band confirms the animal is a cKO (Figure 2B).  Because 
Olig1-Cre is a knockin mutant, homozygous expression of the Olig1-Cre allele causes a 
nonfunctional Olig1 gene, resulting in a lethal phenotype around 2 weeks of birth (Xin et 
al., 2005).  Therefore, animals heterozygous for Olig1-Cre and homozygous for 
Caspase-8fl/fl were used as conditional caspase-8 KO mice for this study. 
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Figure 2 – Caspase-8 deletion strategy.  (A) Specific primers were designed to bind outside of exon 2.  When exon 2 is 
deleted, a 200 bp band is produced.  (B) PCR results with primers from panel A.  Heterozygous animals contain one 
KO and one WT band.  KO animals contain one KO band and partial expression of a floxed band.  Het = 
heterozygous, KO = knockout. 
 
 
 
Conditional knockout of caspase-8 in oligodendrocyte lineage cells leads to an 
increased number of oligodendrocytes in culture 
 To determine the effect of caspase-8 ablation in OLs, mixed glial cultures from 
cKO and heterozygous mice were cultured in different media.  Cells were cultured in 
either DMEM medium containing 1% fetal bovine serum (D1S), BDM (0.1% bovine 
serum albumin, 50 μg/ml human apo-transferrin, 50 μg/ml insulin, 30nM sodium 
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selenite, 10nM d-biotin, and 10 nM hydrocortisone in DMEM), or minimal DMEM 
media for 3 days, and were analyzed by immunocytochemistry for changes in total cell 
number, proliferation, and differentiation.  The OL transcription factor Olig2 was used to 
identify OL lineage cells in the culture grown in D1S medium.  Comparing the number 
of Olig2+ cells across genotypes revealed that there were significantly more OLs in cKO 
cultures compared to heterozygous littermate controls (P < 0.001, Figure 3A). 
Caspase-8 deletion in oligodendrocyte lineage cells does not change oligodendrocyte 
precursor cell proliferation in culture 
To determine why there were more OLs present in cKO cultures, we first 
analyzed OPC proliferation. The OPC marker A2B5 and the OL markers Olig2, and O4 
were used to identify the OL lineage cells in the mixed glial culture.  Analysis of the 
percentage of proliferating OPCs grown in D1S medium, as determined by Ki67 and 
Olig2 double positive OLs divided by the total number of Olig2+ OLs, revealed that 
ablation of caspase-8 in OLs did not affect the cell proliferation (P > 0.05, Figure 3B). 
Deletion of caspase-8 does not affect the differentiation of oligodendrocytes in culture 
 We next investigated possible changes in OPC differentiation due to caspase-8 
deletion.  BDM media is the minimal media that allows for OL growth and 
differentiation; therefore we analyzed the OLs under this experimental condition to 
determine if there were any differences in OPC differentiation due to the deletion of 
caspase-8.  Olig2 staining was again used to determine the total number of OL lineage 
cells while the OL surface marker O4 was used to distinguish more differentiated OLs.  
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The percentage of differentiated, O4+ OLs was found to be statistically the same across 
all genotypes (P > 0.05, Figure 3C).  
 
 
Figure 3 – Effects of caspase-8 deletion in oligodendrocyte physiology in culture.  (A) The numbers of total Olig2+ 
cells were compared across genotypes.  (B) The percentage of Ki67+ OLs were calculated by dividing the number of 
Ki67, Olig2 double positive cells by the total number of Olig2+ cells and compared across genotypes.  (C) The 
percentage of O4+ cells were calculated by dividing the number of O4, Olig2 double positive cells by the total number 
of Olig2+ cells and compared across genotypes.  (D) The percentage of TUNEL+ cells were calculated by dividing the 
number of TUNEL, DAPI double positive cells by the total number of DAPI positive cells and compared across 
genotypes.  n=1-2 independent experiments.  Data analyzed using Student’s t-test. 
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Deletion of caspase-8 in oligodendrocyte lineage cells decreases cell death following 
nutrient deprivation 
 OL cell cultures subjected to nutrient deprivation have been shown to undergo 
apoptosis (Barres et al., 1992).  Therefore, we subjected isolated OLs to minimal DMEM 
media and stained WT and cKO cultures using terminal deoxynucleotidyl transferase 
dUTP nick end labeling (TUNEL) to identify apoptotic cells.    In WT cells, nutrient 
deprivation caused a significant increase in TUNEL+ cells (P < 0.001, Figure 3D).  In 
contrast, in caspase-8 deficient OLs, nutrition deprivation induced apoptotic cell death 
was significantly less as compared to WT (P < 0.001, Figure 3D). 
Caspase-8 deletion leads to an increase in myelinated axons in the spinal cord of 
postnatal day 10 mice 
 Postnatal day 10 animals were perfused and the brains, spinal cords, and optic 
nerves isolated for transmission electron microscopy.  It was found that brain sections at 
this time point were minimally myelinated in the corpus callosum (Figure 4C).   In the 
spinal cord, however, there was a significant increase in the number of myelinated axons 
in cKO animals as compared to littermate WT (P < 0.01, Figure 4A, B).  Optic nerve 
samples were visually inspected for robust differences and a modest increase in 
myelination was noted (Figure 4C).  Further quantification was needed to confirm this 
observation. 
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Figure 4 – Caspase-8 deletion in oligodendrocytes results in more myelinated axons in P10 spinal cord.  (A) 
Myelinated axons were counted in 1800x TEM images of coronally sectioned P10 spinal cords.  Results yielded a p-
value < 0.01.  n=3 animals/WT, n=4 animals/KO.  (B) Representative TEM microscopy images of the spinal cord 
taken from animals of different genotypes.  (C) Representative images of the corpus callosum and optic nerve from 
different genotypes.  Data analyzed using Student’s t-test. 
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Oxidative injury 
Arachidonic acid induces oxidative stress in oligodendrocytes 
 To determine the effect of AA on OLs, isolated OLs were treated with AA 
overnight in the presence or absence of 12-LOX inhibitors baicalein (1 μM) and AA861 
(10 μM), the JNK inhibitor SP600125 (7.5 μM), or 1 μM vitamin K2.  Exposure of OLs 
to AA resulted in cellular swelling and reduced cell viability (P < 0.001, Fig. 5A,C).  
Blockade of 12- LOX with AA861 but not baicalein prevented OLs from cell death (P < 
0.001, P > 0.05, respectively, Figure 5A, D, E), indicating the involvement of 12-LOX in 
AA-induced OL cell death. AA861 appeared to be consistently toxic to neurons; 
therefore baicalein was used for all of the following neuron experiments.  Inhibition of 
JNK by SP600125 and co-treatment with vitamin K2 each resulted in a significant 
protective effect (P < 0.001, Figure 5A, F, G).   These results are consistent with our 
previous findings that AA causes 12-LOX activation and subsequent ROS production, 
leading to cell death (Kim et al., 2010) and that vitamin K2 is protective to developing 
OLs by inhibiting 12-LOX (Li et al., 2009). 
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Figure 5 – Arachidonic acid induces oxidative stress in oligodendrocytes.  (A) Isolated OLs were treated with 60μM 
AA in the presence or absence of 2μM baicalein, 10μM AA861, 7.5μM SP600125, or 1μM vitamin K2.  Cell viability 
was analyzed.  (B-G) Representative phase contrast images for control (B), AA treated in the absence (C), or presence 
of baicalein (D), AA861 (E), SP600125 (F), or vitamin K2 (G).  Scale bar = 50 μm.  n=3-6 independent experiments 
for all drugs tested. 
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Arachidonic acid induces oxidative stress-mediated cell death in cortical neurons 
 To examine whether AA also causes cytotoxicity in primary neurons, we treated 
mature cortical neurons (DIV 14-20) with AA overnight in the presence of 1 μM 
baicalein, 7.5 μM SP600125, or 1 μM vitamin K2.  AA treatment resulted in similar 
morphological changes in neurons as in OLs, and neuronal viability decreased 
significantly (P < 0.001, Fig. 6A, C).   Co-treatment with either 12-LOX or JNK 
inhibitors (baicalien and SP600125, respectively) did not attenuate the loss of cell 
viability (P > 0.05, Figure 6A).  Vitamin K2, however, was able to partially prevent cell 
death (P < 0.01, Figure 6A). 
Since protein expression can change during the development of the brain and 
result in differences in susceptibility to certain stressors, these experiments were 
repeated in immature neurons (DIV 4-7).  We found that AA again induced cell death   
(P < .001, Figure 6B) and neither 12-LOX nor JNK inhibitors ameliorated neuronal cell 
death  (P > .05, Figure 6B).  For both immature and mature neurons, vitamin K2 was 
partially protective (P < 0.01, Figure 6A, B).  To test whether the neuronal cell death 
was related to oxidative stress, we measured cell viability after co-treatment with the 
classical anti-oxidant α-tocopherol (1 μM) and found that it was indeed protective in 
mature neurons (P<.05, Figure 6A) and caused a 36.37% increase in viability in 
immature neurons based on 2 independent experiments.   
OLs have been shown to produce large amounts of ROS after AA treatment (Kim 
et al., 2010). Therefore, we measured ROS production using Rhodamine-123, a 
compound for live-cell imaging that becomes fluorescent when oxidized by peroxides 
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and free radicals.  Neurons were found to produce ROS after AA treatment although not 
as robustly as OLs (Figure 6C).  
 
 
Figure 6 – Arachidonic acid induces oxidative stress in neurons through different mechanisms.  (A-B) Mature (A) or 
immature (B) cortical neurons were treated overnight with AA in the presence or absence of 1μM baicalein, 1μM 
vitamin K2, 7.5μM SP600125, or 1μM tocopherol.  Cell viability was analyzed.  (C) Neurons were treated with AA 
for 5 hrs and then 10μM Rhodamine 123 was diluted into the medium.  ROS production was compared across 
treatment groups.  n=3-6 independent experiments for all drugs tested. 
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Oxidative injury in astrocytes treated with arachidonic acid 
 Because neurons and OLs differed in response to AA, we next asked whether 
astrocytes and OLs share a common cell death pathway.  Astrocytes were co-treated 
overnight with AA and 5 μM baicalein, 7.5 μM SP600125, or 1 μM vitamin K2.  Upon 
AA treatment, astrocyte viability was decreased (P < 0.001, Figure 7A, C).  Blockade of 
12-LOX with baicalein conferred significant protection (P < 0.01, Figure 7A, D).  Co-
treatment with vitamin K2 resulted in complete protection against AA-induced cell death 
(P < 0.001, Figure 7A, F).  So did the JNK inhibitor SP600125 (P < 0.01, Figure 7A, E).  
Although astrocytes exposed to AA exhibited cell swelling similar to that of OLs and 
neurons they developed large vacuoles in their cytoplasm (see below) that were not 
observed in neurons and OLs. 
Alternative mechanisms in astrocytes under oxidative stress  
 Astrocyte responses to AA-induced oxidative injury mirrored that seen in OLs, 
suggesting a common cell death mechanism among glial cells.  There was however a 
distinct difference in morphology in astrocytes treated with AA; they formed a large 
number of vacuoles in the cytoplasm (Figure 8B).  We reasoned that the vacuoles 
forming in AA-treatment astrocytes were probably autophagosomes, a hallmark of cells 
undergoing autophagy (Table 1).  We therefore tested the protective potential of 
autophagosome formation inhibitors 3-methyladenine (3-MA) and bafilomycin A1.  
Bafilomycin appeared to have a modest protective effect, causing a 9.3% increase in 
viability (Figure 8C, F) based on 2 independent experiments. 3-MA appeared to be 
mildly toxic to astrocytes, causing a change in astrocyte morphology and a 15.39% 
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decrease in viability when co-treated with AA (Figure 8C, E).  It remained to be 
determined whether blocking the formation of autophagosomes confers any protective 
effect in astrocytes. 
 
 
Figure 7 – Arachidonic acid induces oxidative stress in astrocytes.  (A) Astrocytes grown 2-3 days in culture were 
treated with AA in the presence or absence of 5μM baicalien, 7.5μM SP600125, or 1μM vitamin K2.  Cell viability 
was analyzed.  (B-F) Representative phase contrast images of control (B), AA treated in the absence (C), or presence 
of baicalein (D), SP600125 (E), or vitamin K2 (F).  Scale bar = 50μm.  n=3-5 independent experiments for all drugs 
tested. 
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Figure 8 – Alternative mechanisms in astrocytes under oxidative stress.  (A-B) Representative phase contrast images 
from control astrocytes (A,*) and AA-treated astrocytes (B).  (C) Astrocytes were treated overnight with AA in the 
presence or absence of 2mM 3-Ma or 10nM bafilomycin.  Cell viability was analyzed.  n=2 independent experiments 
for 3-Ma and bafilomycin, n=6 for control and vehicle conditions.  Data analyzed using Student’s t-test.  (D-F) 
Representative phase contrast images of control (D), AA in the presence of 3-Ma (E), or bafilomycin (F).  Scale bar = 
25 μm (A,B), scale bar = 50 μm (D-F). 
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Live cell imaging in astrocytes  
To examine the nature of these vesicles, we used a fluorescent dye to monitor 
lysozyme formation (300nM LysoTracker).  After AA treatment, LysoTracker imaging 
appeared to show a significant increase in lysosome formation (Figure 9). 
Additionally, cells were stained with JC-1 (1mg/ml) and mitotracker red (20nM) to 
evaluate changes in mitochondrial health after AA treatment.  We utilized JC-1 as an 
indicator of alterations in the mitochondrial membrane potential.  We did not observe 
obvious alterations in mitochondrial membrane potential across treatment groups, as the 
red/green ration appeared very similar (Figure 9).  There was a noticeable reduction in 
mitotracker red staining, which suggests an overall decrease in mitochondrial health 
(Figure 9).   
Zinc release in arachidonic acid-induced oxidative injury 
The heavy metal zinc has been linked to both autophagy and oxidative stress 
(Lee et al., 2009).  To examine the possible involvement of zinc in oxidative injury, we 
co-treated astrocytes with AA and the zinc chelator TPEN (400nM) and AA.  TPEN 
nearly completely abrogated AA-induced cell death (P < .001, Fig. 10A).  To further 
verify the involvement of intracellular zinc release, we then used the zinc-specific 
fluorescent dye FluorZin-3 (1μM) to visualize the location and quantity of zinc in the 
cell.  Following AA treatment, there appeared to be a more diffuse cytoplasmic staining 
which may be indicative of intracellular zinc release (Figure 10B).  TPEN co-treatment 
was also tested in oligodendrocytes and caused a 65.65% decrease in cytotoxicity based 
on 2 independent experiments (Figure 10C).  In neurons, TPEN co-treatment lead to a 
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54.03% decrease in cytotoxicity based on 1 experiment (Figure 10D).  Cytotoxicity was 
determined by measuring the levels of lactate dehydrogenase in the culture medium.  
 
 
 
Figure 9 – Live cell imaging of astrocyte lysosome formation and mitochondrial health.  Astrocytes were treated with 
AA for 3 hrs and then either 50nM LysoTracker, 1μg/ml JC-1, or 20nM Mitotracker Red were added to the culture 
media.  Images are representative of control (left column) and AA-treated (right column) experimental conditions.  
Scale bar = 50 μm. 
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Figure 10 – Zinc release following arachidonic acid treatment.  (A) Astrocytes were treated with AA overnight in the 
presence or absence of 500nM TPEN.  Cell viability was analyzed.  n=4 independent experiments.  (B) Astrocytes 
were treated with AA for 3 hrs and then 1μM Fluorozin-3 was added to the culture medium.  A comparison between 
treatment groups was made.  Scale bar = 50 μm.  (C-D) Cultures were treated identically to panel A for OLs (C) and 
neurons (D) with n=2 and n=1 independent experiments, respectively. 
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Involvement of receptor interacting protein kinase 1 in arachidonic acid-induced cell 
death 
 We have previously demonstrated that RIP-1 becomes activated in OLs after AA 
treatment and is responsible for their necroptotic cell death, since co-treatment with the 
allosteric RIP-1 inhibitor necrostatin-1 completely abolished AA toxicity (Kim et al., 
2010).  We were able to repeat these findings in our paradigm and found that 
necrostatin-1 treatment was protective in OLs (P < .001, Figure 11A).  Necrostatin-1 
also attenuated AA-induced cell death (P < .001, Figure 11B).  In contrast, necrostatin-1 
had no protective effect against AA-induced toxicity in immature and mature cortical 
neurons (P > .05, Figure 11C, D). 
Neurons express low levels of receptor interacting protein kinase 1 
 To further investigate why necrostatin-1 was ineffective in neurons, we then 
examined RIP-1 expression in cultured neurons.  RNA and proteins from mature and 
immature neurons treated with AA for 5 hrs were extracted and subjected to RT-PCR 
and Western blotting analysis respectively.  Neurons were found to express mRNA for 
RIP-1 (Figure 12A).  However, RIP-1 protein was expressed at very low levels in 
neurons as compared to that in glial cells (P < 0.05, Figure 12B, C).  Since OLs, 
microglia, and astrocytes all express RIP-1 mRNA, we asked whether RIP-1 mRNA in 
our neuronal cultures were due to residual glial cell contamination.  The purity of the 
isolated cultures was verified with the exception of microglial contamination in OL 
cultures and mild astrocyte contamination in mature neuron cultures (Figure 12A).   
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Figure 11 – Receptor interacting protein kinase 1 involvement in arachidonic acid-induced toxicity.  (A-D) Cell 
cultures were treated overnight with AA in the presence or absence of 20μM necrostatin-1.  Cell viability was 
analyzed in OLs (A), astrocytes (B), immature neurons (C), and mature neurons (D).  n=3-5 independent experiments. 
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Figure 12 – Receptor interacting protein kinase 1 expression in neurons and glia.  (A) RT-PCR using cDNA from 
unstimulated cells checking for expression of RIP-1, RIP-3, GFAP, Iba-1, and β-actin.  (B) A western blot for RIP-1, 
RIP-3, and β-actin in unstimulated glial and neuronal cultures.  (C) Densitometry normalizing RIP-1 (C) and RIP-3 
(D) expression levels to β-actin in unstimulated neurons and glia.  (E) A western blot for RIP-1, RIP-3, and β-actin in 
neuronal cultures with or without AA treatment.  (F) Densitometry normalizing RIP-1 expression levels to β-actin in 
stimulated and unstimulated neuronal cultures.  MK = MK801, BHA = butylated hydroxyanisole, Mg = microglia.  
n=3-5 independent experiments.  Data analyzed using Student’s t-test.  
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RIP-3 is a cognate kinase to RIP-1 and has been shown be to a crucial member of 
a multi-protein complex to leads to necroptosis (Vandenabeele et al., 2010).  OLs, 
microglia, and astrocytes were found to express RIP-3.  Neurons, interestingly expressed 
little to no RIP-3 at the mRNA and protein level (P > .05, Figure 12A, B, D).  
To determine if RIP-1 expression could be increased under oxidative stress, we 
extracted protein from neurons treated in AA and investigated changes in RIP-1 and 
RIP-3 expression.  We did not observe any increase in expression in cortical neurons 
under oxidative stress (P > .05, Figure 12E, F).  Taken together, cortical neurons appear 
to have minimal expression of RIP-1 and RIP-3, which may account for the inability of 
necrostatin-1 to protect them from AA-induced oxidative injury. 
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CHAPTER IV 
CONCLUSION 
 
Apoptosis 
 Apoptosis is a unique form of programmed cell death characterized by 
morphological hallmarks such as nuclear condensation, membrane blebbing, and cell 
shrinkage (Raff, 1998).  It is known to be essential for the healthy development of the 
CNS (Yuan and Yankner, 2000).  Since OLs are produced in numbers larger than seen in 
the adult brain, the superfluous cells have to be eliminated (Barres et al., 1992, Barres 
and Raff, 1994).  This is accomplished by apoptosis.  A better understanding of cell 
death mechanisms in OL development could potentially lead to better therapeutics in 
demyelinating diseases such as multiple sclerosis, periventricular leukomalacia, and 
other leukodystrophies where decreasing number of OLs has been associated with the 
pathogenesis (Nave, 2010).  Our preliminary data suggests that deletion of caspase-8 in 
OL lineage cells leads to precocious myelination in the spinal cord and that deletion of 
caspase-8 does not affect OPC proliferation or differentiation in culture.  It does, 
however, prevent nutrient deprivation-induced apoptosis (Figure 13).   
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Figure 13 – Proposed schematic of caspase-8 involvement in olligodendrocyte development.  Caspase-8 deletion does 
not have an effect on OPC proliferation or differentiation in-vitro.  Deletion of caspase-8 did, however, lead to fewer 
apoptotic cells following nutrient deprivation in-vitro and more myelinated axons in P10 spinal cord in-vivo. 
 
Recently caspase-8 has been shown to have functions influencing healthy 
physiology, especially in immune cells (Siegel, 2006, Koenig et al., 2008, Burguillos et 
al., 2011).  Therefore, it was necessary to examine the effect of caspase-8 deficiency on 
normal OL physiology such as the rate of proliferation and the ability to differentiate.  
OL proliferation and differentiation, in particular, are critical processes in CNS 
myelination (Hardy and Reynolds, 1991, Levison and Goldman, 1993).  Mixed glial 
cultures prepared from WT and cKO mice were cultured in D1S media for 3 days, more 
OLs were found in the caspase-8 cKO cultures (Figure 3A).  Further investigation 
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revealed that the increase in Olig2+ cells in the cKO mixed glial cultures was not due to 
an increase in the rate of cell proliferation (Figure 3B) nor due to more differentiated 
OLs (Figure 3C).   Instead, the difference was likely due to an inhibition of OL lineage 
cell death in culture (Figure 3D).  Apoptosis can be initiated by multiple stimuli, 
including nutrient deprivation.  Further studies need to be conducted to investigate the 
effect of caspase-8 deletion as on death receptor, TNF and Fas induced OL apoptosis. 
Caspase-8 is classically involved in receptor-induced apoptosis, it is worth noting that 
these were only preliminary experiments, having been performed only once and need to 
be repeated several times before a definitive conclusion can be made.  Nevertheless, our 
preliminary results were in line with our hypothesis that caspase-8 deletion in OL 
lineage cells would impair apoptotic cell death.  
In-vivo, ablation of capsase-8 leads to an increase in the number of myelinated 
axons in the spinal cord at postnatal day 10 (Figure 4A, B).  At postnatal day 10, there 
was minimal myelination in the brain to compare across genotypes (Figure 4C).  Initial 
visual inspection of the optic nerve revealed a possible difference across genotypes but 
the number of myelinated axons needs to be counted before a conclusion can be drawn 
(Figure 4C).  The spinal cord and optic nerve are myelinated very early in development; 
therefore the difference we noticed across genotypes in the spinal cord could be 
occurring in the brain as well at a later time point.  In the future, proliferation, 
differentiation, and cell death markers need to be utilized in immunohistochemical 
analysis of developmental tissues at different time points.   
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 In conclusion, this portion of our study began the investigation into the role of 
caspase-8 in OL lineage cells during normal CNS development.  In addition to the need 
to repeat the experiments performed in this study, further studies can be conducted to 
investigate the function of caspase-8 in demyelinating pathological states as well as an 
impact on remyelination.  Apoptosis of OLs is thought to be involved in numerous 
pathological conditions, such as prenatal white matter injury due to hypoxia/ischemia 
(Hu et al., 2000, Lesuisse and Martin, 2002, Feng et al., 2003).  Additionally, 
dysregulation of programmed cell death has been implicated in neurodegenerative, 
traumatic, ischemic, metabolic, and demyelinating disorders (Nakamura and Lipton, 
2009, Kuo et al., 2010, Qin et al., 2010, Gregory and Pound, 2011).  Direct use of 
antibodies against cleaved caspases as therapeutics has also been demonstrated to reduce 
neurodegeneration (Friedlander et al., 1997, Yang et al., 1998, Ona et al., 1999, Galvan 
et al., 2006).  Therefore, the advancement of understanding in the role of programmed 
cell death in CNS pathology could lead to viable cellular targets to reduce or prevent 
damage in a tissue that has little to no self-regenerative capacity.  
Oxidative injury 
Oxidative stress is defined primarily as the loss of a cell’s ability to manage the 
production and elimination of oxidative radicals (Finkel and Holbrook, 2000).  It has 
been implicated in many neurological diseases, such as stroke (van Leyen et al., 2006), 
periventricular leukomalacia (Inder et al., 2002), Parkinson’s disease (Thompson et al., 
2000), and Alzheimer’s disease (Behl et al., 1992, Behl et al., 1994).  In this study, we 
investigated the cellular signaling events following AA-induced oxidative death in OLs, 
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astrocytes, and neurons.  We demonstrate that following AA treatment, OLs, astrocytes, 
and neurons undergo oxidative injury-induced cell death through different mechanisms.   
In OLs, AA induces oxidative stress-mediated necroptotic cell death, as indicated 
by the protective effect of both 12- LOX and RIP-1 inhibitors (Figure 5, 11).  This is in 
agreement with previous findings (Kim et al., 2010) showing that AA treatment leads to 
receptor-independent RIP-1 activation.  Astrocytes were protected by 12-LOX and RIP-
1 inhibitors from AA-induced oxidative stress as well.  However, they undergo different 
morphological changes, namely a noticeable increase in lysosome formation.  This was 
observed both through live cell imaging and pharmacological inhibition (Figure 7, 8).  
Treatment of astrocytes with autophagosome inhibitors was only mildly protective, but 
not statistically significant (Figure 8).  Oxidative stress can be exacerbated by other 
cellular events, such as heavy metal release.  Zinc has been implicated in oxidative stress 
(Zhang et al., 2007).  Increases in intracellular levels have been shown to lead to rapid 
cell death (Choi and Koh, 1998, Frederickson et al., 2005).  Zinc has also been shown to 
be associated with autophagic vacuoles (Lee et al., 2009). We found that astrocytes, 
OLs, and neurons were all protected by zinc chelation (Figure 10).  It is possible that 
oxidative stress caused by AA metabolism leads to zinc release, which in turn causes 
lysosome formation and RIP-1, 12-LOX, and JNK activation.  Further research is needed 
to elucidate the mechanism that leads to zinc release and whether zinc release is an 
upstream event in AA-induced oxidative cell death in astrocytes, OLs, and neurons. 
Neurons, we observed, undergo oxidative stress when treated with AA.  The 
mechanisms that lead to their cell death, however, differ markedly from that of OLs and 
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astrocytes.  Neither 12-LOX nor JNK inhibition had any protective effect in neurons 
(Figure 6).  Only vitamin K2 and α-tocopherol were partially protective (Figure 6).  
Necrostatin-1 was also ineffective (Figure 11), in agreement with very low expression of 
RIP-1 and RIP-3 proteins in neurons (Figure 12).  The positive RIP-1 mRNA expression 
we found via PCR could be due to astrocyte contamination (approximately 5%), as we 
were able to amplify GFAP from RNA samples isolated from mature neuron cultures 
(Figure 12A).  At the protein level, however, RIP-1 is undetectable and would therefore 
be non-functional in neurons (Figure 12B, C).  Considerable further research is needed 
to elucidate the mechanisms underlying AA-induced neuronal oxidative death.   
It is very intriguing that neurons do not express significant amounts of RIP-1.  In 
animal models of cerebral hypoxia/ischemia (Degterev et al., 2005), The RIP-1 inhibitor, 
necrostatin-1, has been shown to reduce infarct volume, suggesting that necroptosis is an 
important event in cerebral hypoxia/ischemia.  However, the cellular target of 
necrostatin-1 has yet to be established.  Our results suggest that the protection may 
actually be due nectrostatin-1’s effect on glial cells (Allen and Barres, 2005, Freeman 
and Doherty, 2006, Wang and Bordey, 2008, Allen and Barres, 2009). 
In conclusion, our study suggests that CNS cells possess different cell death 
mechanisms and responses to oxidative stress as well as shared mediators such as ROS 
and zinc (Figure 14).  This could be of importance in conditions in which increases in 
AA levels and oxidative stress are important pathological events.  Based on our findings, 
glial cells appear to have similar cell death mechanisms that are distinct from the 
neuronal population, influencing potential therapeutic strategies.  This expands upon 
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previous research showing an in-vivo protective effect of necrostatin-1 in animal models 
of stroke (Degterev et al., 2005).  Taken together, our results imply that protected glial 
cells possess the ability to maintain neuronal health in a harsh environment.  Future 
research will be needed to deduce how glial cells provide this support under these 
conditions. 
 
 
Figure 14 – Proposed schematic of arachidonic acid-induced toxicity.  AA is metabolized primarily by lipoxygenases, 
which leads to lipid hydroperoxide and ROS production.  This can be inhibited with baicalein, AA861, or vitamin K2.  
ROS can be eliminated by tocopherol.  ROS production leads to activation of RIP-1/3 and JNK.  RIP-1 can be blocked 
by necrostatin-1 and JNK can be blocked by SP600125.  ROS production also leads to zinc release, which can be 
attenuated by the zinc chelator TPEN. 
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